New study monitors ultomiris safety for pregnant women and their babies

NCT ID NCT06312644

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 28 times

Summary

This study looks at the safety of the drug Ultomiris when used during pregnancy. Researchers will track 75 pregnant or postpartum women who take Ultomiris for conditions like PNH or aHUS. They will record pregnancy complications, maternal health issues, and infant health outcomes up to 1 year after birth.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    RECRUITING

    Boston, Massachusetts, 02210, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Research Site

    NOT_YET_RECRUITING

    Melbourne, Victoria, 3050, Australia

    Contact

  • Research Site

    RECRUITING

    Paris, 75475, France

    Contact

  • Research Site

    RECRUITING

    Essen, Norte-Westfalia, D-45147, Germany

    Contact

  • Research Site

    RECRUITING

    Rome, 00168, Italy

    Contact

  • Research Site

    ACTIVE_NOT_RECRUITING

    Seoul, South Korea

  • Research Site

    ACTIVE_NOT_RECRUITING

    London, SE5 9NU, United Kingdom

Conditions

Explore the condition pages connected to this study.